Bell Investment Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bell Investment Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$1.58K	–	1955
2023 Q4	$1.58K	Sell	5 -1	-17%	-$194	﹤0.01%	1432
2023 Q3	$1.01K	Buy	6 +3	+100%	+$564	﹤0.01%	1567
2023 Q2	$651	Sell	3 -3	-50%	-$643	﹤0.01%	1723
2023 Q1	$1.09K	Buy	6 +3	+100%	+$574	﹤0.01%	1532
2022 Q4	$590	Sell	3 -5	-63%	-$1.07K	﹤0.01%	1738
2022 Q3	$2K	Sell	8 -58	-88%	-$11.7K	﹤0.01%	1271
2022 Q2	$8K	Buy	+66	New	+$7.58K	﹤0.01%	531

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bell Investment Advisors's KRTX Position: Q1 2024 in Review

Bell Investment Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5 shares — an estimated $1.58K sold.

Bell Investment Advisors first reported a position in KRTX in Q2 2022 and held it in 7 quarters. The position peaked at $8K in Q2 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Bell Investment Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bell Investment Advisors sold 5 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.58K.
Bell Investment Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Bell Investment Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $8K in Q2 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bell Investment Advisors's 13F filing for Q1 2024, filed 8 May 2024.